SCHEMBL30799418

SCHEMBL30799418

NCCCC[C@H](NC(=O)[C@@H](N)CCC(N)=O)C(N)=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP8 Q6V1X1 3/20 0.49
DPP9 Q86TI2 3/20 0.49
DPP4 P27487 2/20 0.49
DPP7 Q9UHL4 2/20 0.43
NOD1 Q9Y239 1/20 0.42
FOLH1 Q04609 1/20 0.42
ALOX15 P16050 1/20 0.42
BLM P54132 1/20 0.42
PMP22 Q01453 1/20 0.42
KMT2A Q03164 1/20 0.42
GSR P00390 1/20 0.41
GNAI3 P08754 1/20 0.40
GNAO1 P09471 1/20 0.40
GNAI1 P63096 1/20 0.40
HPGDS O60760 1/20 0.40
TLR2 O60603 1/20 0.39
ERAP2 Q6P179 1/20 0.39
ERAP1 Q9NZ08 1/20 0.39
LNPEP Q9UIQ6 1/20 0.39
NMT2 O60551 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30399386 0.93 NOD1 (0.45) DPP8DPP9DPP4DPP7NOD1
SCHEMBL7570529 0.90 DPP8 (0.51) DPP8DPP9DPP4DPP7NOD1
SCHEMBL30148762 0.89 FOLH1 (0.55) DPP8DPP9DPP4DPP7NOD1
SCHEMBL397257 0.89 FOLH1 (0.55) DPP8DPP9DPP4DPP7NOD1
SCHEMBL7563979 0.89 FOLH1 (0.55) DPP8DPP9DPP4DPP7NOD1
SCHEMBL16421653 0.89 FOLH1 (0.55) DPP8DPP9DPP4DPP7NOD1
SCHEMBL5334900 0.89 FOLH1 (0.55) DPP8DPP9DPP4DPP7NOD1
SCHEMBL27562795 0.89 DPP8 (0.50) DPP8DPP9DPP4DPP7NOD1
SCHEMBL27584028 0.89 DPP8 (0.50) DPP8DPP9DPP4DPP7NOD1
SCHEMBL27767761 0.88 FOLH1 (0.54) DPP8DPP9DPP4DPP7NOD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240116985-A1 STAPLED PEPTIDES AND METHODS THEREOF PARABILIS MEDICINES, INC. 2024-04-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240116985-A1 STAPLED PEPTIDES AND METHODS THEREOF CTNNB1, APC, CTNNA1 DPP8 231/4885DPP9 205/4885DPP4 552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.